Quick answers
- What is Fluocinolone acetonide used for?
- The FDA-approved label (Synalar, Medimetriks Pharmaceuticals, Inc., July 18, 2024) says: “SYNALAR ® Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteriod-responsive dermatoses.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Fluocinolone acetonide have a boxed warning?
- No. None of the 43 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Fluocinolone acetonide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Fluocinolone acetonide been recalled?
- FDA enforcement reports list 14 recalls of products of this medicine; the newest started December 30, 2025 (Class III). A recall usually concerns specific lots, not every product.
- Who makes Fluocinolone acetonide?
- 18 companies list prescription products of Fluocinolone acetonide in the FDA NDC Directory, including Bryant Ranch Prepack, ANI Pharmaceuticals, Inc. and Rising Pharma Holdings, Inc..
What Fluocinolone acetonide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
SYNALAR ® Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteriod-responsive dermatoses.
— FDA label: Synalar, Medimetriks Pharmaceuticals, Inc., effective July 18, 2024. Read the full label on DailyMed →
The FDA has 43 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 43 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Oil · Solution · Cream · Ointment · Implant |
|---|---|
| Route | Topical · Auricular (otic) · Intravitreal |
| Prescription products | 46 in the FDA NDC Directory |
| Brand names | Fluocinolone Acetonide Oil, Derma-Smoothe/Fs, Synalar, Yutiq, Flac Otic Oil, Dermotic, Iluvien |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| fluocinolone acetonide 0.01 mg/100 mL oil | Generic | $0.1663–$0.1759 per mL 2 packages, lowest to highest |
| fluocinolone acetonide 0.01% cream | Generic | $1.23–$1.59 per gram 4 packages, lowest to highest |
| fluocinolone acetonide 0.025% cream | Generic | $1.03–$1.37 per gram 4 packages, lowest to highest |
| fluocinolone acetonide 0.025% ointment | Generic | $0.5637–$1.33 per gram 6 packages, lowest to highest |
| fluocinolone acetonide 0.1 mg/mL solution | Generic | $0.2267 per mL |
| fluocinolone acetonide 0.11 mg/118.28 mL oil | Generic | $0.1663–$0.1759 per mL 2 packages, lowest to highest |
| fluocinolone acetonide 0.11 mg/mL oil | Generic | $0.1663–$0.9066 per mL 7 packages, lowest to highest |
| fluocinolone acetonide 0.11 mg/mL oil | Brand: Derma-Smoothe/FS | $0.2426 per mL |
| fluocinolone acetonide 0.11 mg/mL oil | Brand: Derma-Smoothe/Fs | $0.2419 per mL |
| fluocinolone acetonide 0.11 mg/mL oil | Brand: Dermotic | $1.13 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack12 products
- ANI Pharmaceuticals, Inc.5 products
- Rising Pharma Holdings, Inc.3 products
- Padagis Israel Pharmaceuticals Ltd3 products
- Sun Pharmaceutical Industries, Inc.3 products
- Cosette Pharmaceuticals, Inc.3 products
- Quagen Pharmaceuticals LLC3 products
- Royal Pharmaceuticals2 products
- Medimetriks Pharmaceuticals, Inc.2 products
- A-S Medication Solutions2 products
- Royal Pharmaceuticals, LLC1 product
- Actavis Pharma, Inc.1 product
- Fougera Pharmaceuticals, LLC1 product
- Patrin Pharma, Inc.1 product
- E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC1 product
- Lupin Pharmaceuticals, Inc.1 product
- Encube Ethicals, Inc.1 product
- Amneal Pharmaceuticals LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA012787 SYNALAR | Eurofarma | February 15, 1963 | 39, latest March 28, 2013 2013: Manufacturing (CMC) · 2000: Manufacturing (CMC) · 1996: Manufacturing (CMC) |
| NDA013960 SYNALAR | Eurofarma | June 19, 1963 | 35, latest September 26, 2000 2000: Manufacturing (CMC) · 1995: Labeling · 1995: Labeling |
| NDA019452 DERMA-SMOOTHE/FS, DERMOTIC | Hill Dermac | February 3, 1988 | 23, latest August 30, 2024 2024: Labeling · 2020: Labeling · 2016: Manufacturing (CMC) |
| NDA201923 ILUVIEN | Alimera Sciences Inc | September 26, 2014 | 3, latest March 12, 2025 2025: Labeling · 2017: Labeling · 2015: Manufacturing (CMC) |
| NDA210331 YUTIQ | Alimera Sciences Inc | October 12, 2018 | — |
Generic approvals (22)
- ANDA088167Fougera Pharms Inc · December 16, 1982
- ANDA088168Fougera Pharms Inc · December 16, 1982
- ANDA089124Sun Pharma Canada · September 11, 1985
- ANDA089524Cosette Pharms Nc · July 26, 1988
- ANDA089526Cosette Pharms Nc · July 26, 1988
- ANDA201759Amneal · October 17, 2011
- ANDA202847Padagis Israel · August 9, 2013
- ANDA202848Padagis Israel · August 9, 2013
- ANDA206422Lupin · September 2, 2015
- ANDA090982Rising · April 25, 2016
- ANDA203377Rising · April 25, 2016
- ANDA203378Rising · April 25, 2016
- ANDA202368Sun Pharma Canada · May 19, 2016
- ANDA209336Sun Pharma Canada · May 19, 2016
- ANDA208386Actavis Labs Ut Inc · October 21, 2016
- ANDA202849Padagis Israel · July 17, 2017
- ANDA210736Anda Repository · April 11, 2018
- ANDA210747Cosette Pharms Nc · November 5, 2018
- ANDA209913Encube Ethicals · February 13, 2019
- ANDA212760Quagen · April 2, 2021
- ANDA212761Quagen · April 2, 2021
- ANDA212762Quagen · April 2, 2021
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 30, 2025 · Class III · Ongoing · D-0256-2026
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 — SUN PHARMACEUTICAL INDUSTRIES INC
-
November 4, 2021 · Class II · Terminated · D-0234-2022
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-703-86 — Amneal Pharmaceuticals of New York, LLC
-
May 21, 2021 · Class II · Terminated · D-0637-2021
Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.
DermOtic Oil (fluocinolone acetonide oil) 0.01% Ear Drops 20 mL bottles, Rx only, Manufactured by: Hill Dermaceuticals, Inc. Sanford, FL 32773 for: Royal Pharmaceuticals Manasquan, NJ 08736, NDC 68791-103-20 — Hill Dermaceuticals, Inc.
-
January 15, 2019 · Class II · Terminated · D-0390-2019
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.
Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; NDC 43386-06 — LUPIN SOMERSET
-
October 5, 2018 · Class II · Terminated · D-0092-2019
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis
Fluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, MD 21202 Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-069-60 — LUPIN SOMERSET
-
July 5, 2018 · Class II · Terminated · D-0909-2018
Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.
Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ 07054 USA, N — Teva Pharmaceuticals USA
-
April 13, 2018 · Class II · Terminated · D-0712-2018
Subpotent Drug
Fluocinolone Acetonide Topical Oil, 0.01% (Ear Drops) 20 mL, Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-329-20, UPC — Lyne Laboratories, Inc.
-
April 13, 2018 · Class II · Terminated · D-0711-2018
Subpotent Drug
Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil) 118.28 mL (4 fl. oz.) Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 6498 — Lyne Laboratories, Inc.
-
April 13, 2018 · Class II · Terminated · D-0713-2018
Subpotent Drug
Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 6498 — Lyne Laboratories, Inc.
-
February 22, 2017 · Class III · Terminated · D-0653-2017
Chemical Contamination
Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use, 60 mL bottle, Rx Only, Manufactured for Gavis Pharmaceuticals, LLC, Somerset NJ 08873, Manufactured by Novel Laboratories, I — Novel Laboratories, Inc.
-
January 31, 2014 · Class III · Terminated · D-1178-2014
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
ROYAL PHARMACEUTICALS DermOtic Oil fluocinolone acetonide 0.01% (Ear Drops), 20 ml, Rx only Manufactured by: Hill Dermaceuticalsfor: Royal Pharmaceuticals NDC 68791-103-20 — Hill Dermaceuticals, Inc.
-
January 31, 2014 · Class III · Terminated · D-1176-2014
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical Oil (Body Oil) 4 fl. oz., Rx only Manufactured by: Hill Dermaceuticals, Inc. for: Royal Pharmaceuticals NDC 68791-101-04 — Hill Dermaceuticals, Inc.
-
January 31, 2014 · Class III · Terminated · D-1177-2014
Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01% (Scalp Oil), 4 fl.oz., Rx only Manufactured by: Hill Dermaceuticals for: Royal Pharmaceuticals NDC 68791-102-04 — Hill Dermaceuticals, Inc.
-
September 30, 2013 · Class III · Terminated · D-391-2014
Failed Content Uniformity Specifications; at the 18 month time point.
G & W Fluocinolone Acetonide Cream USP 0.025%, a) 15 gm (NDC 0713-0222-15), b) 60 gm (NDC 0713-0222-60 ), Rx Only, Manufactured by: G&W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080 — G & W Laboratories Inc
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 1191256, 1191260, 1191299, 1191301, 1191302, 1191307, 1191309, 1191310, 1191315, 1191319 … (+5) |
|---|---|
| SPL set ID of the quoted label | 5af2e4c1-082b-48a0-aae7-72d4a68cbb2d |
| FDA labels (SPL) | 43 |
| FDA applications | NDA012787, NDA013960, NDA019452, NDA201923, NDA210331, 22 ANDA |
| Active ingredients (FDA) | FLUOCINOLONE ACETONIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Synalar, Medimetriks Pharmaceuticals, Inc., effective July 18, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →